Open AccessP575: IMPACT OF MOLECULAR RESPONSE AND CHEMOTHERAPY REGIMEN ON OUTCOMES IN CORE BINDING FACTOR AML
Author(s) -
Senapati J.,
Haddad F.,
Ravandi F.,
Kadia T.,
DiNardo C.,
Daver N.,
Pemmaraju N.,
Alvarado Y.,
Brandt M. A.,
Kantarjian H.,
Borthakur G.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845188.92355.0a
Subject(s) - fludarabine , cytarabine , medicine , idarubicin , flag (linear algebra) , oncology , minimal residual disease , myeloid leukemia , regimen , leukemia , gastroenterology , chemotherapy , cyclophosphamide , mathematics , pure mathematics , algebra over a field